LLYXDefiance Daily Target 2X Long LLY ETF
Seeks daily investment results of 200% the daily percentage change in the share price of Eli Lilly and Company.
By Defiance ETFs LLC · Launched 2024
Annual Cost
1.49%
#5,850 of 6,040 · expensive
Fund Size
$41M
#3,950 of 6,040 · mid-size
Return (1Y)
+77.9%
Track Record
2 years
#3,654 of 6,040 · seasoned
Performance
Total-return NAV · USDGrowth of $10,000
$18,001+80.0%
Total-return NAV, USD. Net of fund fees, before tax.
What's inside
How Beacon categorizes this fundAsset class
EquityStrategy
Leveraged
Holdings
By weightConcentration
single-stock exposure — holdings shown are derivatives collateral, not the fund's position
TREASURY BILL
30.8%
First American Government Obli
10.0%
N/A
5.2%
N/A
3.9%
N/A
3.8%
N/A
3.5%
N/A
2.4%
N/A
2.1%
Asset allocation
Stocks
153.8%
Other
65.8%
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsVolatility (1Y)
70.8%High
Year-on-year price swings
Max drawdown
-68.0%Severe
Worst peak-to-trough loss
Sharpe (3Y)
Unavailable
Needs 3+ years of history
Sortino (3Y)
Not yet
Needs 3+ years of history
Listing
- Exchange
- NYSE Arca
Full fund details
- Objective
- Seeks daily investment results of 200% the daily percentage change in the share price of Eli Lilly and Company.
- Strategy
- Actively managed ETF aiming for 200% daily exposure to the share price of Eli Lilly (LLY) using derivatives like swaps and options. Concentrated in the pharmaceutical industry.
- Inception date
- August 8, 2024
- Fund family
- Defiance ETFs LLC
Similar funds
Same asset class, closest by strategy & exposureNext steps
Save LLYX to compare it with other funds, or start building a portfolio.
Data updated on 2026-09-18